Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6Urinary Bladder Neoplasms 2Prostatic Hyperplasia 1Precancerous Conditions 1

Interventions

Dutasteride 5acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2Transurethral Resection of Prostate 2Therapeutics 2Radiotherapy 2Prostatectomy 2Blood Specimen Collection 2proxalutamide 1polyphenon E 1mirabegron 1Urination 1TroVax 1Transurethral Resection of Bladder 1Tamsulosin 1Standard of Care 1Risedronic Acid 1Psychiatric Rehabilitation 1Prostate-Specific Antigen 1Papaverine 1Oxygen 1Nitrous Oxide 1Needles 1Microspheres 1Magnetic Resonance Spectroscopy 1Lycopene 1Levofloxacin 1Finasteride 1Electroacupuncture 1Doxazosin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Hyperplasia × polyphenon E × Genitourinary × Clear all
NCT00596011 2019-10-04

Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
97 enrolled 13 charts
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡